<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 07 Apr 2021 17:24:00 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>306家药企晒2020成绩单！超40家亏损，77家翻倍，云南白药、复星……狂赚超30亿</title><link>https://mp.weixin.qq.com/s/YF2rsKyKDr6qyakdI4GMcg</link><description></description><content:encoded><![CDATA[306家药企晒2020成绩单！超40家亏损，77家翻倍，云南白药、复星……狂赚超30亿]]></content:encoded><pubDate>Wed, 07 Apr 2021 16:18:34 +0800</pubDate></item><item><title>【瞩目】扬子江遇劲敌！科伦、倍特、石药……围攻30亿注射剂</title><link>https://mp.weixin.qq.com/s/LLTG1kN6_yt5yQKvyln6GQ</link><description></description><content:encoded><![CDATA[【瞩目】扬子江遇劲敌！科伦、倍特、石药……围攻30亿注射剂]]></content:encoded><pubDate>Wed, 07 Apr 2021 16:18:34 +0800</pubDate></item><item><title>【获批】人福大爆发！两大注射剂过评，抗痴呆药拿下ANDA</title><link>https://mp.weixin.qq.com/s/NpJAUeSCqcq7b3sUPKWvEA</link><description></description><content:encoded><![CDATA[【获批】人福大爆发！两大注射剂过评，抗痴呆药拿下ANDA]]></content:encoded><pubDate>Wed, 07 Apr 2021 16:18:34 +0800</pubDate></item><item><title>【FDA】又一款CAR-T细胞疗法面世！3月5款创新药获批</title><link>https://mp.weixin.qq.com/s/HCcQLLNnyKcAZmH5wLsllQ</link><description></description><content:encoded><![CDATA[【FDA】又一款CAR-T细胞疗法面世！3月5款创新药获批]]></content:encoded><pubDate>Wed, 07 Apr 2021 16:18:34 +0800</pubDate></item><item><title>大卖168亿创新高！配方颗粒龙头大显身手，中国中药、红日、神威……暴涨原因是？</title><link>https://mp.weixin.qq.com/s/tzmXzEMx6TMKQXE9wi58Xg</link><description></description><content:encoded><![CDATA[大卖168亿创新高！配方颗粒龙头大显身手，中国中药、红日、神威……暴涨原因是？]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:55:57 +0800</pubDate></item><item><title>【重磅】健康元再冲击吸入剂新药！14个在研产品已有4个新药</title><link>https://mp.weixin.qq.com/s/DGone_o_eHXJll4HZXxATw</link><description></description><content:encoded><![CDATA[【重磅】健康元再冲击吸入剂新药！14个在研产品已有4个新药]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:55:57 +0800</pubDate></item><item><title>【火爆】20亿注射剂，海思科首家过评！辉瑞份额跌至四成</title><link>https://mp.weixin.qq.com/s/aKfIDWc0UsC-bUQHJhXUzg</link><description></description><content:encoded><![CDATA[【火爆】20亿注射剂，海思科首家过评！辉瑞份额跌至四成]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:55:57 +0800</pubDate></item><item><title>【焦点】零售市场暴涨九成的抗菌注射剂，奥赛康即将获批</title><link>https://mp.weixin.qq.com/s/aFcnoFt-B6-x2yj_Y_QA0A</link><description></description><content:encoded><![CDATA[【焦点】零售市场暴涨九成的抗菌注射剂，奥赛康即将获批]]></content:encoded><pubDate>Tue, 06 Apr 2021 16:55:57 +0800</pubDate></item><item><title>2020年全球抗体药物市场超$1500亿，五大靶点“聚宝盆”出炉，国内PD-1/PD-L1翻了TNFα的车？</title><link>https://mp.weixin.qq.com/s/2cVkefv14C3c8u_5lthMWw</link><description></description><content:encoded><![CDATA[2020年全球抗体药物市场超$1500亿，五大靶点“聚宝盆”出炉，国内PD-1/PD-L1翻了TNFα的车？]]></content:encoded><pubDate>Mon, 05 Apr 2021 07:57:01 +0800</pubDate></item><item><title>新药研发道阻且长，百奥泰并未言败</title><link>https://mp.weixin.qq.com/s/eow07Ziorb4vzB4YuekGhQ</link><description></description><content:encoded><![CDATA[新药研发道阻且长，百奥泰并未言败]]></content:encoded><pubDate>Sun, 04 Apr 2021 07:57:39 +0800</pubDate></item><item><title>3月CDE：46个存量品种过评，4个1类新药、6个首仿获批；这三个重磅品种申报新适应症上市</title><link>https://mp.weixin.qq.com/s/owIeQSvW9-pVVB1-pGd1WQ</link><description></description><content:encoded><![CDATA[3月CDE：46个存量品种过评，4个1类新药、6个首仿获批；这三个重磅品种申报新适应症上市]]></content:encoded><pubDate>Sun, 04 Apr 2021 07:57:39 +0800</pubDate></item><item><title>10个药品遭重点监控！知名药企被重罚2千万，信立泰、豪森……43个药品采购“叫停”</title><link>https://mp.weixin.qq.com/s/eKOLXnHW9kmmJGHlHwQWBA</link><description></description><content:encoded><![CDATA[10个药品遭重点监控！知名药企被重罚2千万，信立泰、豪森……43个药品采购“叫停”]]></content:encoded><pubDate>Sat, 03 Apr 2021 07:55:11 +0800</pubDate></item><item><title>一季度医药股TOP20！恒瑞、迈瑞对飚5000亿市值，片仔癀稳居中药股一哥，CRO三巨头亮眼</title><link>https://mp.weixin.qq.com/s/Aw5OQ5xJSz2GfZsmNMbHBQ</link><description></description><content:encoded><![CDATA[一季度医药股TOP20！恒瑞、迈瑞对飚5000亿市值，片仔癀稳居中药股一哥，CRO三巨头亮眼]]></content:encoded><pubDate>Fri, 02 Apr 2021 16:46:08 +0800</pubDate></item><item><title>【瞩目】国产第3家，倍特拿下6亿抗血栓药！口服降糖药抢首仿</title><link>https://mp.weixin.qq.com/s/fNHE0TMUbZhuqWqRmHxsoQ</link><description></description><content:encoded><![CDATA[【瞩目】国产第3家，倍特拿下6亿抗血栓药！口服降糖药抢首仿]]></content:encoded><pubDate>Fri, 02 Apr 2021 16:46:08 +0800</pubDate></item><item><title>【关注】正大天晴、齐鲁、豪森……围攻7亿抗肿瘤药！原研药再受冲击</title><link>https://mp.weixin.qq.com/s/9tiAxnk-vlG4uwWw_PtNZw</link><description></description><content:encoded><![CDATA[【关注】正大天晴、齐鲁、豪森……围攻7亿抗肿瘤药！原研药再受冲击]]></content:encoded><pubDate>Fri, 02 Apr 2021 16:46:08 +0800</pubDate></item><item><title>【获批】浙江药企入局100亿重磅品种！华润、鲁抗9家紧跟而至</title><link>https://mp.weixin.qq.com/s/_ZV-bddz8UdCroPdUnX6iw</link><description></description><content:encoded><![CDATA[【获批】浙江药企入局100亿重磅品种！华润、鲁抗9家紧跟而至]]></content:encoded><pubDate>Fri, 02 Apr 2021 16:46:08 +0800</pubDate></item><item><title>20款吸入剂厉害了！8个1类新药、20个首仿来袭，正大天晴亮了，成都倍特发力</title><link>https://mp.weixin.qq.com/s/1aGF8aFjIavollO_lu3GcQ</link><description></description><content:encoded><![CDATA[20款吸入剂厉害了！8个1类新药、20个首仿来袭，正大天晴亮了，成都倍特发力]]></content:encoded><pubDate>Thu, 01 Apr 2021 16:06:30 +0800</pubDate></item><item><title>【喜讯】符合第五批集采品种注射用更昔洛韦，普利制药再下一城获意大利批准</title><link>https://mp.weixin.qq.com/s/3r7ppeypOEePa3U5q56aiQ</link><description></description><content:encoded><![CDATA[【喜讯】符合第五批集采品种注射用更昔洛韦，普利制药再下一城获意大利批准]]></content:encoded><pubDate>Thu, 01 Apr 2021 16:06:30 +0800</pubDate></item><item><title>【瞩目】这家药企开挂了，两款创新药接连获批</title><link>https://mp.weixin.qq.com/s/MKv-yG1OpAnaKcVXrAu2Fw</link><description></description><content:encoded><![CDATA[【瞩目】这家药企开挂了，两款创新药接连获批]]></content:encoded><pubDate>Thu, 01 Apr 2021 16:06:30 +0800</pubDate></item><item><title>【关注】助力疼痛康复，藏医药蓄势待发</title><link>https://mp.weixin.qq.com/s/TobKddSlq-Q28m17x0yS0A</link><description></description><content:encoded><![CDATA[【关注】助力疼痛康复，藏医药蓄势待发]]></content:encoded><pubDate>Thu, 01 Apr 2021 16:06:30 +0800</pubDate></item></channel></rss>